Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype

被引:1
作者
Liu, Zhe-Bin [1 ,3 ]
Wu, Jiong [1 ,3 ]
Ping, Bo [2 ,3 ]
Feng, Li-Qing [2 ,3 ]
Di, Gen-Hong [1 ,3 ]
Lu, Jin-Song [1 ,3 ]
Shen, Kun-Wei [1 ,3 ]
Shen, Zhen-Zhou [1 ,3 ]
Shao, Zhi-Min [1 ,3 ]
机构
[1] Fudan Univ, Breast Canc Inst, Dept Breast Surg, Shanghai 200032, Peoples R China
[2] Fudan Univ, Canc Hosp, Inst Canc, Dept Pathol, Shanghai 200032, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
来源
TUMORI JOURNAL | 2009年 / 95卷 / 01期
关键词
breast neoplasm; basal; keratin; prognosis; PROGNOSTIC-FACTORS; PATTERNS; MARKERS; CLASSIFICATION; SURVIVAL; SUBTYPES; BENIGN; TUMORS; MODEL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background. To evaluate the immunohistochemical characterization of CK5/6 and CK17 and whether the expression level of the two markers was correlated with clinical outcome or pathological feature in triple negative (ER-, PR-, HER-2-) patients with breast cancer. Methods and study design. We carried out an immunohistochemical assay for CK5/6 and CK17 markers on formalin-fixed invasive carcinoma samples from 112 patients who were diagnosed between 2000 and 2002. All of them had an immunohistochemical triple negative status and follow-Lip information available. Results. Of the 112 patients characterized by triple negative immunohistochemical status, 82 (73.2%) were disease free with no relapse or metastasis. In total, CK5/6 and CK17 were both determined positive in 33.9% (38/112) of the 112 tumor samples, and 46.4% (52/112) were regarded as positive for CK5/6 or CK17. The Kaplan-Meier Curve showed that positive staining for CK5/6, CK17, or CK which means CK5/6 positive or CK17 positive, was associated with worse disease-free survival (P = 0.020, P = 0.032, P = 0.003), and positive staining for CK5/6 or CK was associated with worse overall survival (P = 0.027, P = 0.015). When we considered 91 patients whose pathological type was invasive ductal carcinoma, we found that there was also an association between CK5/6 or CK17 immunostaining and high grade (P = 0.030). In addition, these two markers were also associated with axillary lymph node status (P = 0.044). The Cox regression multiple-factor analysis showed that pathological stage, grade and expression of CK were the factors affecting both disease-free and overall survival, whereas age and menopausal status were independent factors affecting disease-free and overall survival, respectively. Conclusions. Positive staining for CK5/6 or CK17 was associated with a worse prognosis, high tumor grade and positive axillary lymph nodes,
引用
收藏
页码:53 / 62
页数:10
相关论文
共 31 条
[1]   High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses [J].
Abd El-Rehim, DM ;
Ball, G ;
Pinder, SE ;
Rakha, E ;
Paish, C ;
Robertson, JFR ;
Macmillan, D ;
Blamey, RW ;
Ellis, IO .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (03) :340-350
[2]   Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].
Carey, Lisa A. ;
Perou, Charles M. ;
Livasy, Chad A. ;
Dressler, Lynn G. ;
Cowan, David ;
Conway, Kathleen ;
Karaca, Gamze ;
Troester, Melissa A. ;
Tse, Chiu Kit ;
Edmiston, Sharon ;
Deming, Sandra L. ;
Geradts, Joseph ;
Cheang, Maggie C. U. ;
Nielsen, Torsten O. ;
Moorman, Patricia G. ;
Earp, H. Shelton ;
Millikan, Robert C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502
[3]   EXPRESSION OF BASAL AND LUMINAL EPITHELIUM-SPECIFIC KERATINS IN NORMAL, BENIGN, AND MALIGNANT BREAST-TISSUE [J].
DAIRKEE, SH ;
PUETT, L ;
HACKETT, AJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (09) :691-695
[4]  
DAIRKEE SH, 1987, LANCET, V1, P514
[5]   Triple-negative breast cancer: Clinical features and patterns of recurrence [J].
Dent, Rebecca ;
Trudeau, Maureen ;
Pritchard, Kathleen I. ;
Hanna, Wedad M. ;
Kahn, Harriet K. ;
Sawka, Carol A. ;
Lickley, Lavina A. ;
Rawlinson, Ellen ;
Sun, Ping ;
Narod, Steven A. .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4429-4434
[6]   Expression of luminal and basal cytokeratins in human breast carcinoma [J].
El-Rehim, DMA ;
Pinder, SE ;
Paish, CE ;
Bell, J ;
Blamey, R ;
Robertson, JFR ;
Nicholson, RI ;
Ellis, IO .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :661-671
[7]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[8]   The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer [J].
Foulkes, WD ;
Brunet, JS ;
Stefansson, IM ;
Straume, O ;
Chappuis, PO ;
Bégin, LR ;
Hamel, N ;
Goffin, JR ;
Wong, N ;
Trudel, M ;
Kapusta, L ;
Porter, P ;
Akslen, LA .
CANCER RESEARCH, 2004, 64 (03) :830-835
[9]   MONOCLONAL-ANTIBODY MAPPING OF KERATIN-8 AND KERATIN-17 AND OF VIMENTIN IN NORMAL HUMAN MAMMARY-GLAND, BENIGN-TUMORS, DYSPLASIAS AND BREAST-CANCER [J].
GUELSTEIN, VI ;
TCHYPYSHEVA, TA ;
ERMILOVA, VD ;
LITVINOVA, LV ;
TROYANOVSKY, SM ;
BANNIKOV, GA .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (02) :147-153
[10]   Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer [J].
Gusterson, BA ;
Ross, DT ;
Heath, VJ ;
Stein, T .
BREAST CANCER RESEARCH, 2005, 7 (04) :143-148